Pulse Zuvio Inaugurates Critical Care Manufacturing Unit at AMTZ Visakhapatnam
Pulse Zuvio Pvt Ltd was officially inaugurated at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam during the World Health Day celebrations on April 8. It marks a major step forward in India's drive to manufacture critical care medical equipment at home.
The inauguration was led by Dr. Harsh Vardhan, former Union Minister of Health and Family Welfare, alongside Dr. Jitendra Sharma, Managing Director and Founder CEO of AMTZ. The event was part of a broader push to position India as a global hub for medical technology. On the same day, 25 startups signed Letters of Intent (LoIs) for incubation at AMTZ.
What the new unit will build
The Pulse Zuvio facility will manufacture a portfolio of critical care devices designed and engineered for Indian hospital settings, including:
- Patient monitors
- Automated External Defibrillators (AEDs)
- Syringe pumps
- Dialysis machines
India has historically depended on imports for these categories, despite strong domestic demand. The AMTZ unit gives Pulse Zuvio direct access to the country's first integrated medical-device manufacturing ecosystem. This includes shared infrastructure for component testing, EMI labs, sterilisation, and regulatory readiness.
Why AMTZ matters
AMTZ is a 270-acre dedicated medical-device manufacturing zone set up by the Government of Andhra Pradesh. By housing capital-intensive facilities under one roof, it cuts manufacturing costs for individual medical-device companies by 40–50%. This structural advantage helps Indian manufacturers compete with global companies on both price and quality.
Speaking at the event, Dr. Harsh Vardhan highlighted India's transition from import dependence to indigenous capability in medical technology, noting that the AMTZ ecosystem is not just producing devices but "building strategic confidence" for the nation.
From enabling 100% indigenous hospitals under the 'Make in India Hospital' initiative to advancing inclusive innovation through dedicated MedTech venture ecosystems, AMTZ's focus remains clear: to solve critical healthcare challenges with scalable, homegrown solutions. — Dr. Jitendra Sharma, MD & Founder CEO, AMTZ
Where this fits for Pulse
The Zuvio inauguration follows Pulse's $4 million seed round led by 3one4 Capital earlier this year. It is a concrete step in turning that funding into a real manufacturing footprint. With AMTZ as a base, Pulse Zuvio extends Pulse's full-stack model of design, sourcing, manufacturing and service into a category where domestic supply has long lagged demand.
The day also saw the foundation stone laid for Truevis Technologies, focused on linear actuators and advanced cancer care solutions, further strengthening AMTZ's critical-care manufacturing cluster.